Industry
Biotronik Japan, Inc.
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT05426785Not ApplicableActive Not Recruiting
To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)
Role: collaborator
NCT07118358Not ApplicableNot Yet Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Role: collaborator
NCT01523704Not ApplicableCompleted
Safety and Efficacy Study of IPG Patient With Home Monitoring
Role: lead
NCT01221649Phase 4Completed
Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement in Japan (J-HomeCARE II)
Role: lead
All 4 trials loaded